Literature DB >> 7809152

Sleep patterns are disturbed in cats infected with feline immunodeficiency virus.

O Prospéro-García1, N Herold, T R Phillips, J H Elder, F E Bloom, S J Henriksen.   

Abstract

Human immunodeficiency virus (HIV)-related sleep disturbances have been reported early in AIDS. Likewise, the feline immunodeficiency virus (FIV), a natural lentivirus pathogen of cats, produces a similar immunodeficiency syndrome with neurological sequelae. To identify the neurophysiological substrate of FIV infection in brain, pathogen-free cats were infected with the Maryland strain of FIV. Eight weeks after inoculation, all FIV-infected cats seroconverted and virus was detected in the cerebrospinal fluid and in the mononuclear cells of peripheral blood. Ten to 12 months after the FIV inoculation, inoculated and control cats were surgically implanted with electrodes to record the sleep/wake cycle. These sleep recordings were obtained under conditions controlling for environmental variables and instrumental adaptation. FIV-infected cats spent 50% more time awake than the sham-inoculated controls and exhibited many more sleep/waking stage shifts--i.e., 40% more than controls. In addition, FIV-infected cats showed approximately 30% of rapid eye movement (REM) sleep reduction compared to controls. The latency to sleep and REM sleep onset was also significantly delayed in FIV-infected cats. In addition, a remarkable increase in cortically recorded spindle activity (8-13 Hz) was observed during slow-wave sleep in some infected subjects, similar to changes described in HIV-infected humans. Moreover, infected cats exhibited no overt signs of systemic morbidity, such as hyperpyrexia or body weight loss. These results indicate that FIV-infected cats exhibit sleep abnormalities similar to the sleep disturbances previously described in AIDS patients and further support the feline preparation as a valuable animal model of HIV infection of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809152      PMCID: PMC45557          DOI: 10.1073/pnas.91.26.12947

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Binding of HIV-1 gp120 to the nicotinic receptor.

Authors:  L Bracci; L Lozzi; M Rustici; P Neri
Journal:  FEBS Lett       Date:  1992-10-19       Impact factor: 4.124

2.  Sleep disturbances in HIV-infected homosexual men.

Authors:  S E Norman; A D Chediak; M Kiel; M A Cohn
Journal:  AIDS       Date:  1990-08       Impact factor: 4.177

3.  Clinical and laboratory findings in cats infected with feline immunodeficiency virus.

Authors:  C D Hopper; A H Sparkes; T J Gruffydd-Jones; S M Crispin; P Muir; D A Harbour; C R Stokes
Journal:  Vet Rec       Date:  1989-09-23       Impact factor: 2.695

4.  Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS)

Authors:  E N Miller; O A Selnes; J C McArthur; P Satz; J T Becker; B A Cohen; K Sheridan; A M Machado; W G Van Gorp; B Visscher
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

5.  Fatigue, sleep disturbance, disability, and indices of progression of HIV infection.

Authors:  D F Darko; J A McCutchan; D F Kripke; J C Gillin; S Golshan
Journal:  Am J Psychiatry       Date:  1992-04       Impact factor: 18.112

Review 6.  Models of neuronal injury in AIDS: another role for the NMDA receptor?

Authors:  S A Lipton
Journal:  Trends Neurosci       Date:  1992-03       Impact factor: 13.837

7.  Intraventricular administration of a FIV-envelope protein induces sleep architecture changes in rats.

Authors:  O Prospéro-García; N Herold; A K Waters; T R Phillips; J H Elder; S J Henriksen
Journal:  Brain Res       Date:  1994-10-03       Impact factor: 3.252

8.  Nucleotide sequence and genomic organization of feline immunodeficiency virus.

Authors:  R L Talbott; E E Sparger; K M Lovelace; W M Fitch; N C Pedersen; P A Luciw; J H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Early viral brain invasion in iatrogenic human immunodeficiency virus infection.

Authors:  L E Davis; B L Hjelle; V E Miller; D L Palmer; A L Llewellyn; T L Merlin; S A Young; R G Mills; W Wachsman; C A Wiley
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

10.  Comparison of early and late feline immunodeficiency virus encephalopathies.

Authors:  M Hurtrel; J P Ganière; J F Guelfi; L Chakrabarti; M A Maire; F Gray; L Montagnier; B Hurtrel
Journal:  AIDS       Date:  1992-04       Impact factor: 4.177

View more
  19 in total

Review 1.  In vitro and animal models of human immunodeficiency virus infection of the central nervous system.

Authors:  Chadd E Nesbit; Stanley A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  CXCR4 is the primary receptor for feline immunodeficiency virus in astrocytes.

Authors:  K Nakagaki; K Nakagaki; K Takahashi; D Schols; E De Clercq; T Tabira
Journal:  J Neurovirol       Date:  2001-10       Impact factor: 2.643

3.  Effects of feline immunodeficiency virus on astrocyte glutamate uptake: implications for lentivirus-induced central nervous system diseases.

Authors:  N Yu; J N Billaud; T R Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 4.  Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV.

Authors:  John H Elder; Ying-Chuan Lin; Elizabeth Fink; Chris K Grant
Journal:  Curr HIV Res       Date:  2010-01       Impact factor: 1.581

5.  Methamphetamine and lentivirus interactions: reciprocal enhancement of central nervous system disease.

Authors:  Salvador Huitron-Resendiz; Steven J Henriksen; Margaret C Barr; Maria P Testa; Elena Crawford; Loren H Parsons; Manuel Sanchez-Alavez; Tom R Phillips
Journal:  J Neurovirol       Date:  2010-07       Impact factor: 2.643

6.  Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134.

Authors:  Chris K Grant; Elizabeth A Fink; Magnus Sundstrom; Bruce E Torbett; John H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

7.  Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3.

Authors:  Salvador Huitron-Resendiz; Sohela De Rozières; Manuel Sanchez-Alavez; Bernd Bühler; Ying-Chuan Lin; Danica L Lerner; Nicholas W Henriksen; Mboya Burudi; Howard S Fox; Bruce E Torbett; Steven Henriksen; John H Elder
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 8.  Molecular mechanisms of FIV infection.

Authors:  John H Elder; Magnus Sundstrom; Sohela de Rozieres; Aymeric de Parseval; Chris K Grant; Ying-Chuan Lin
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

9.  Infection of the choroid plexus by feline immunodeficiency virus.

Authors:  D C Bragg; T A Childers; M B Tompkins; W A Tompkins; R B Meeker
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

10.  Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression.

Authors:  C Power; R Buist; J B Johnston; M R Del Bigio; W Ni; M R Dawood; J Peeling
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.